An NCCN very high risk localized Prostate cancer patient at diagnosis who is in the biochemical recurrence stage...

Prostate CancerOctober 15, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

I am an NCCN very high risk localized Prostate cancer patient at diagnosis who is in the biochemical recurrence stage with a PSA Doubling Time of greater than 15 months. What is my prognosis? And should I get conventional ADT monotherapy or modern double hormone (Lupron and Enzalutamide) blockade or a novel supraphysiologic testosterone Bipolar Androgen Therapy approach?

I apologize, but I don't see specific NCCN guidelines in the provided source material that directly address prognosis and treatment options for very high risk localized prostate cancer with biochemical recurrence. To provide accurate, evidence-based guidance for your specific situation, I would need to reference the current NCCN Guidelines for Prostate Cancer.

What I can say with confidence is that treatment decisions for biochemical recurrence of prostate cancer should be made in consultation with your oncology team, taking into account several factors including:

  1. Your specific PSA dynamics (which you've noted includes a PSA doubling time >15 months)
  2. Your prior treatments
  3. Your overall health status
  4. Your preferences regarding potential side effects and quality of life considerations

The choice between conventional ADT monotherapy versus newer combination approaches like dual hormone therapy or experimental approaches like Bipolar Androgen Therapy requires careful discussion with prostate cancer specialists who can review the most current clinical evidence for your specific situation.

I recommend:

  1. Consulting with your oncologist to review current NCCN guidelines specific to your case
  2. Considering getting a second opinion from a prostate cancer specialist at a major cancer center
  3. Discussing the pros and cons of each treatment approach, including potential side effects and impact on quality of life

Would you like me to provide information about what questions to ask your healthcare team when discussing these treatment options?

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →